Results 161 to 170 of about 2,747,113 (394)

Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease [PDF]

, 2014
Nisha Bansal, Dongjie Fan, Chi‐yuan Hsu, Juan D. Ordoñez, Alan S. Go   +4 more
openalex   +1 more source

Cardiovascular disease in chronic kidney disease

European Heart Journal
Abstract Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients.
Katharina Marx-Schütt, David Z I Cherney, Joachim Jankowski, Kunihiro Matsushita, Massimo Nardone, Nikolaus Marx   +5 more
openaire   +2 more sources

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

Kidney International, 2022
P. Rossing, M. L. Caramori, J. Chan, H. Heerspink, Clint Hurst, K. Khunti, A. Liew, E. Michos, S. Navaneethan, W. Olowu, Tami Sadusky, N. Tandon, K. Tuttle, C. Wanner, K. Wilkens, S. Zoungas, I. D. de Boer   +16 more
semanticscholar   +1 more source

Imaging of Lipid Droplets in Living Cells and Mice with Metabolic Dysfunction‐Associated Steatotic Liver Disease via a Galactose‐Modified Supramolecular Near‐Infrared Fluorescent Glycoprobe

Advanced Functional Materials, EarlyView.
A galactose‐modified supramolecular near‐infrared (NIR) glycoprobe, TCF‐FBN@Gal‐BSA, enables targeted delivery to the liver through the asialoglycoprotein receptor (ASGPR) and facilitates liver‐targeting fluorescence visualization of lipid droplets (LDs) in metabolic dysfunction‐associated steatotic liver disease (MASLD) mice.
Han‐Min Wang, Lei Dong, Qiu‐Lian Hao, Lu‐Lu Sun, Xin‐Rong Li, Yu‐Wei Yuan, Ming‐Ye Tang, Jin Gong, Yi Zang, Jia Li, Tony D. James, Xiao‐Peng He, Hai‐Hao Han   +12 more
wiley   +1 more source

Emerging evidence on the role of clonal hematopoiesis of indeterminate potential in chronic kidney disease [PDF]

, 2022
Zhijie Huang, Caitlyn Vlasschaert, Cassianne Robinson‐Cohen, Yang Pan, Xiao Sun, James P. Lash, Bryan Kestenbaum, Tanika N. Kelly   +7 more
openalex   +1 more source

Pengaruh Penyakit Ginjal Kronik Terhadap Disfungsi Ereksi Pria [PDF]

, 2014
: Chronic kidney disease is decreased in kidney function that persistent and irreversible. Chronic kidney disease can lead to problems in the erectile function of men because of disorders on some factors, that are the endocrine system, the vascular ...
Simanjuntak, B. N. (Boni)
core  

Adalimumab‐Poloxamer Conjugate for Bio‐Better: Enhanced Stability and Function

Advanced Functional Materials, EarlyView.
Antibody‐polymer conjugates, particularly poloxamer conjugates, enhance antibody stability by improving tolerance to physicochemical stress and attenuating proteolysis by proteases. Furthermore, the higher affinity observed with poloxamer conjugation compared to standard PEGylation results in improved therapeutic efficacy in rheumatoid arthritis mouse ...
Jaewon Roh, Sanghee Lee, Soomin Cho, Kun Na   +3 more
wiley   +1 more source

Consequences of chronic kidney disease in chronic obstructive pulmonary disease [PDF]

, 2019
Franziska Trudzinski, M Alqudrah, Albert Omlor, Stephen Zewinger, Danilo Fliser, Thimoteus Speer, Frederik Seiler, Frank Biertz, Armin Koch, Claus Vogelmeier, Tobias Welte, Henrik Watz, Benjamin Waschki, Sebastian Fähndrich, Rudolf A. Jörres, Robert Bals   +15 more
openalex   +1 more source

Non‐resolution of acute kidney injury in the first week portends the development of chronic kidney disease in critically ill patients with cirrhosis [PDF]

, 2023
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Ashini Hidam, Archana Rastogi, Sherin Thomas, Guresh Kumar, Anupam Kumar, Shiv Kumar Sarin   +7 more
openalex   +1 more source

A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease

Kidney Diseases
Introduction: This study aimed to develop and validate machine learning (ML) models based on serum Klotho for predicting end-stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with chronic kidney disease (CKD).
Yating Wang, Yu Shi, Tangli Xiao, Xianjin Bi, Qingyu Huo, Shaobo Wang, Jiachuan Xiong, Jinghong Zhao   +7 more
doaj   +1 more source